Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
This is a 33.3% decrease from the number of companies cited in the previous quarter.
The citations in the county include:
- You did not validate that your process controls are adequate to control the hazard.
- A process whose results cannot be fully verified by subsequent inspection and test has not been validated according to established procedures.
- The information required by the Global Unique Device Identification Database for each medical device version or model required to bear a unique device identifier (UDI) was not provided.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Avox Systems, Inc. | Devices | 02/02/2024 | Lack of or inadequate process validation |
Avox Systems, Inc. | Devices | 02/02/2024 | Devices subject to device identification GUDID data submission requirements. |
Fruit Fresh Up, Inc. | Food and Cosmetics | 03/21/2024 | Process controls - Validation |